Publication: Interleukin-8 in Hyperlipidemia and Coronary Heart Disease in Thai Patients Taking Statin Cholesterol-Lowering Medication while Undergoing Coronary Artery Bypass Grafting Treatment
dc.contributor.author | Wilanee Dechkhajorn | en_US |
dc.contributor.author | Yaowapa Maneerat | en_US |
dc.contributor.author | Kriengchai Prasongsukarn | en_US |
dc.contributor.author | Panan Kanchanaphum | en_US |
dc.contributor.author | Ratchanok Kumsiri | en_US |
dc.contributor.other | Rangsit University | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Phramongkutklao College of Medicine | en_US |
dc.date.accessioned | 2020-08-25T08:56:35Z | |
dc.date.available | 2020-08-25T08:56:35Z | |
dc.date.issued | 2020-01-01 | en_US |
dc.description.abstract | © 2020 Wilanee Dechkhajorn et al. The role of interleukin-8 (IL-8), a pivotal chemokine in atherogenesis and coronary heart disease (CHD) development, is diverse and remains unclear. This cross-sectional study investigates the association of the IL-8 expression in hyperlipidemia (H) and CHD patients who have been treated with statin cholesterol-lowering drugs while undergoing coronary artery bypass grafting treatment. Fifty-five Thai volunteers including 13 normal (N), 24 H, and 18 CHD patients were enrolled for the investigation. All the CHD patients had been treated continuously with statin cholesterol-lowering medications since the disease was diagnosed and were undergoing coronary bypass grafting approximately one month later. Therefore, the CHD group was representative of a pathogenesis improvement in CHD. The IL8 mRNA expression was determined by real-time quantitative PCR in the peripheral blood mononuclear cells from heparinized blood. The plasma IL-8 levels were assessed by enzyme-linked immunosorbent assay. The result shows that the IL8 mRNA expression in the H group tended to increase; however, in the CHD group, there was a significant decrease (p=0.0111) compared to the N group. The IL8 mRNA expression and the plasma levels in the CHD group were significantly lower than those in the H group (p<0.05). A significant negative correlation between the IL8 mRNA (r = -0.499) or plasma IL-8 (r = -0.3875) expression and CHD progression was observed (p<0.05). In conclusion, the transcriptomic and the phenotypic IL-8 expression decreased significantly in the Thai CHD patients who had continuously received statin-group medications compared to the H and N group participants. Therefore, IL-8 should serve as a feasible marker and could be used to evaluate the therapeutic effects of statins and illustrate the pathology of CHD treatment. | en_US |
dc.identifier.citation | Scientifica. Vol.2020, (2020) | en_US |
dc.identifier.doi | 10.1155/2020/5843958 | en_US |
dc.identifier.issn | 2090908X | en_US |
dc.identifier.other | 2-s2.0-85087975971 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/57634 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087975971&origin=inward | en_US |
dc.subject | Agricultural and Biological Sciences | en_US |
dc.subject | Environmental Science | en_US |
dc.title | Interleukin-8 in Hyperlipidemia and Coronary Heart Disease in Thai Patients Taking Statin Cholesterol-Lowering Medication while Undergoing Coronary Artery Bypass Grafting Treatment | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087975971&origin=inward | en_US |